The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
التاريخ
2023المؤلف
Khalil ,Ibrahim A.Aldeeb ,Maya
Mohammed ,Ahmed
Awad ,Khalid
Ibrahim ,Tarek
Al-Zoubi ,Raed M.
Aboumarzouk ,Omar M
Al-Rumaihi ,Khalid
...show more authors ...show less authors
البيانات الوصفية
عرض كامل للتسجيلةالملخص
Background: Benign prostatic hyperplasia is the most common cause of urinary retention in men (BPH). The gold standard surgical treatment is transurethral resection of the prostate (TURP). However, due to the morbidity and mortality associated with TURP, more minimally invasive treatments, such as vaporizing the prostate with the Rezum system, have been introduced. We investigated the efficacy of Rezum in the treatment of refractory urinary retention due to BPH in this review. Methodology and materials: To conduct this review, the Cochrane methodology for systematic reviews was used. All studies that used Rezum to treat catheter-dependent patients with enlarged prostates were included. The literature search showed 111 studies, 84 of which were excluded due to non-relevance based on titles and 18 due to lack of relevance based on abstract review. Full manuscripts were reviewed in nine studies, three of which were excluded because they did not meet the inclusion criteria. Results: This review included 301 patients in total. The rate of a successful trial of voiding post Rezum therapy was 85%. The complication rated between 3.8 and 4.3% all of which were mild and self-limited. As there was no major complication of Rezum (clavien dindo >2), the procedure-related morbidity is negligible. Conclusion: In this review, Rezum was found to be an efficacious and safe alternative in the treatment of refractory retention with mild complications and minimal morbidity.
المجموعات
- العلوم الحيوية الطبية [697 items ]
- أبحاث الطب [1397 items ]